AQUILUS PHARMACEUTICALS, INC.

Basic Information

225 MYSTIC VALLEY PKWY
WINCHESTER, MA, 01890-3130

Company Profile

n/a

Additional Details

Field Value
DUNS: 830934324
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Metalloproteinase Inhibitor For Pain and Morphine Tolerance Due To Thermal Injury

    Amount: $261,982.00

    DESCRIPTION (provided by applicant): Aquilus Pharmaceuticals, Inc. proposes to evaluate the effects of a proprietary matrix metalloproteinase (MMP) inhibitor, AQU-010, for blocking neuropathic pain an ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Selective Matrix Metalloproteinase Inhibitors For Osteoarthritis

    Amount: $373,995.00

    DESCRIPTION (provided by applicant): Aquilus Pharmaceuticals, Inc. proposes to evaluate the effects of two novel matrix metalloproteinase (MMP) inhibitors in both the medial meniscal tear (MMT) and m ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. MMP Inhibitor For Orofacial Pain

    Amount: $250,000.00

    DESCRIPTION (provided by applicant): Aquilus Pharmaceuticals, Inc. proposes to evaluate the effects of a novel matrix metalloproteinase (MMP) inhibitor on animal behavioral models of spinal and orofac ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government